Tom Buchanan joined Thermo Fisher Scientific in 2018 as a European Bio/Pharma Applications Development Scientist from Allergan Biologics where he was a Biopharmaceutical Characterization Scientist within Analytical Development. At Allergan he was responsible for the development of LC-UV/LC-MS peptide mapping methods for biologics, in particular, monoclonal antibodies, to determine critical
quality attributes and intact mass methods for product identification. Tom has expertise in cGMP downstream bioproduction and quality control, as well as in-process batch testing, stability studies, and analytical method validation.
Read More